Loading...
•
Dec 31, 2024
GE HealthCare Q4 2024 Earnings Report
Key Takeaways
GE HealthCare reported 2.17% revenue growth in Q4 2024, reaching $5.319 billion. Strong performance in Advanced Visualization Solutions and Pharmaceutical Diagnostics drove results, alongside improved operating and net margins. Adjusted earnings per share grew 22.88% year-over-year.
GE HealthCare
GE HealthCare
GE HealthCare Revenue by Segment
Revenue by Segment
Imaging Revenue
CapyFin.comPatient Care Solutions Revenue
CapyFin.comPharmaceutical Diagnostics Revenue
CapyFin.com Forward Guidance
GE HealthCare expects 2%-3% organic revenue growth in 2025, with margin expansion and adjusted EPS growth of 3%-6%. The company will continue investing in innovation and operational efficiency.
Positive Outlook
- Expected 2%-3% organic revenue growth
- Adjusted EBIT margin expansion of 40-50 basis points
- Adjusted EPS growth of 3%-6%
- Sustained demand in Pharmaceutical Diagnostics and Advanced Visualization
- Investment strategy in AI and advanced diagnostics
Challenges Ahead
- Impact of tariffs on products from China
- Ongoing market weakness in China
- Inflationary pressures on operating costs
- Higher financing costs due to interest rates
- Increasing competition in the medical diagnostics sector
Revenue & Expenses
Visualization of income flow from segment revenue to net income